Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Item
http://www.wikidata.org/entity/Q37030839
Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial.One Year of Glaucoma Research in Review: 2012 to 2013.Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews.Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice.Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial.Tear biomarkers in latanoprost and bimatoprost treated eyes
P2860

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Item
http://www.wikidata.org/entity/Q37030839
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bimatoprost 0.03% preservative ...... andomised, double-masked trial
@en
Bimatoprost 0.03% preservative ...... ndomised, double-masked trial.
@nl
type
label
Bimatoprost 0.03% preservative ...... andomised, double-masked trial
@en
Bimatoprost 0.03% preservative ...... ndomised, double-masked trial.
@nl
prefLabel
Bimatoprost 0.03% preservative ...... andomised, double-masked trial
@en
Bimatoprost 0.03% preservative ...... ndomised, double-masked trial.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Bimatoprost 0.03% preservative ...... andomised, double-masked trial
@en
P2093
P2860
P304
P31
P356
10.1136/BJOPHTHALMOL-2012-303040
P407
P433
P478
P577
P5875
P698
P921
P932